These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 24524898)
1. Improving the systemic drug delivery efficacy of nanoparticles using a transferrin variant for targeting. Chiu RY; Tsuji T; Wang SJ; Wang J; Liu CT; Kamei DT J Control Release; 2014 Apr; 180():33-41. PubMed ID: 24524898 [TBL] [Abstract][Full Text] [Related]
2. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. Gan CW; Feng SS Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685 [TBL] [Abstract][Full Text] [Related]
3. Transferrin conjugated poly (γ-glutamic acid-maleimide-co-L-lactide)-1,2-dipalmitoylsn-glycero-3-phosphoethanolamine copolymer nanoparticles for targeting drug delivery. Zhao C; Liu X; Liu J; Yang Z; Rong X; Li M; Liang X; Wu Y Colloids Surf B Biointerfaces; 2014 Nov; 123():787-96. PubMed ID: 25454663 [TBL] [Abstract][Full Text] [Related]
4. Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles. Xu Q; Liu Y; Su S; Li W; Chen C; Wu Y Biomaterials; 2012 Feb; 33(5):1627-39. PubMed ID: 22118775 [TBL] [Abstract][Full Text] [Related]
5. Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice. Yhee JY; Lee SJ; Lee S; Song S; Min HS; Kang SW; Son S; Jeong SY; Kwon IC; Kim SH; Kim K Bioconjug Chem; 2013 Nov; 24(11):1850-60. PubMed ID: 24107100 [TBL] [Abstract][Full Text] [Related]
6. Endocytic mechanism of transferrin-conjugated nanoparticles and the effects of their size and ligand number on the efficiency of drug delivery. Tsuji T; Yoshitomi H; Usukura J Microscopy (Oxf); 2013 Jun; 62(3):341-52. PubMed ID: 23204307 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of transferrin iron release increases in vitro drug carrier efficacy. Lao BJ; Tsai WL; Mashayekhi F; Pham EA; Mason AB; Kamei DT J Control Release; 2007 Feb; 117(3):403-12. PubMed ID: 17239470 [TBL] [Abstract][Full Text] [Related]
8. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Sahoo SK; Labhasetwar V Mol Pharm; 2005; 2(5):373-83. PubMed ID: 16196490 [TBL] [Abstract][Full Text] [Related]
9. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. Cui Y; Xu Q; Chow PK; Wang D; Wang CH Biomaterials; 2013 Nov; 34(33):8511-20. PubMed ID: 23932498 [TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Li X; Ding L; Xu Y; Wang Y; Ping Q Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296 [TBL] [Abstract][Full Text] [Related]
11. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors. Han L; Huang R; Liu S; Huang S; Jiang C Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964 [TBL] [Abstract][Full Text] [Related]
12. A transferrin variant as the targeting ligand for polymeric nanoparticles incorporated in 3-D PLGA porous scaffolds. Lopes AM; Chen KY; Kamei DT Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():373-380. PubMed ID: 28183621 [TBL] [Abstract][Full Text] [Related]
13. Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid. Porru M; Zappavigna S; Salzano G; Luce A; Stoppacciaro A; Balestrieri ML; Artuso S; Lusa S; De Rosa G; Leonetti C; Caraglia M Oncotarget; 2014 Nov; 5(21):10446-59. PubMed ID: 25431953 [TBL] [Abstract][Full Text] [Related]
14. One-Step Self-Assembling Method to Prepare Dual-Functional Transferrin Nanoparticles for Antitumor Drug Delivery. Wang K; Yuan A; Yu J; Wu J; Hu Y J Pharm Sci; 2016 Mar; 105(3):1269-76. PubMed ID: 26886339 [TBL] [Abstract][Full Text] [Related]
15. Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization. Vaidya B; Vyas SP J Drug Target; 2012 May; 20(4):372-80. PubMed ID: 22339366 [TBL] [Abstract][Full Text] [Related]
16. Selective cellular uptake and induction of apoptosis of cancer-targeted selenium nanoparticles. Huang Y; He L; Liu W; Fan C; Zheng W; Wong YS; Chen T Biomaterials; 2013 Sep; 34(29):7106-16. PubMed ID: 23800743 [TBL] [Abstract][Full Text] [Related]
17. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation. Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956 [TBL] [Abstract][Full Text] [Related]
18. Transferrin- and folate-modified, double-targeted nanocarriers for gene delivery. Jing F; Li D; Xu W; Liu Y; Wang K; Sui Z Pharm Biol; 2014 May; 52(5):570-4. PubMed ID: 24256214 [TBL] [Abstract][Full Text] [Related]
19. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT. Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793 [TBL] [Abstract][Full Text] [Related]
20. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]